Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Accelerate Diagnostics, Inc. (AXDX) To Contact The Firm

AXDX

NEW YORK, March 13, 2015 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Accelerate Diagnostics, Inc. ("Accelerate" or the "Company") (NasdaqCM: AXDX).

Faruqi & Faruqi, LLP

The investigation focuses on whether the Company and its executives violated federal securities laws making materially false and misleading statements regarding the Company's business, operations, and prospects.

On February 18, 2015, an article published on the website www.SeekingAlpha.com revealed that Accelerate had falsely represented that its technology BACcel involves a technique for diagnosing pathogens in a blood sample without a need for using a blood culture. In reality, BACcel does require a blood culture which significantly reduces the value of the technology. 

Following this news, Accelerate stock declined by $4.04 per share, or more than 18%, closing on February 20, 2015 at $18.05 per share. 

Request more information now by clicking here: www.faruqilaw.com/AXDX. There is no cost or obligation to you.

Take Action

If you invested in Accelerate stock or options through February 18, 2015 and would like to discuss your legal rights, visit www.faruqilaw.com/AXDX.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Accelerate's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-50000-investing-in-accelerate-diagnostics-inc-axdx-to-contact-the-firm-300050438.html

SOURCE Faruqi & Faruqi, LLP



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today